Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The use and implementation of omalizumab as food allergy treatment: Consensus-based guidance and Work Group Report of the Adverse Reactions to Foods Committee of the American Academy of Allergy, Asthma & Immunology.
Anagnostou A, Bird JA, Chinthrajah S, Dribin TE, Fleischer DM, Kim E, Nowak-Wegrzyn A, Rachid R, Shaker MS, Shreffler W, Sicherer S, Tam J, Vickery BP, Virkud YV, Wang J, Young M, Greenhawt M. Anagnostou A, et al. Among authors: virkud yv. J Allergy Clin Immunol. 2025 Jan;155(1):62-69.e1. doi: 10.1016/j.jaci.2024.09.031. Epub 2024 Nov 22. J Allergy Clin Immunol. 2025. PMID: 39580718
Metabolomics of IgE-Mediated Food Allergy and Oral Immunotherapy Outcomes based on Metabolomic Profiling.
Virkud YV, Styles JN, Kelly RS, Patil SU, Ruiter B, Smith NP, Clish C, Wheelock CE, Celedón JC, Litonjua AA, Bunyavanich S, Weiss ST, Baker ES, Lasky-Su JA, Shreffler WG. Virkud YV, et al. medRxiv [Preprint]. 2024 Jun 1:2024.05.31.24308233. doi: 10.1101/2024.05.31.24308233. medRxiv. 2024. Update in: Pediatr Allergy Immunol. 2024 Nov;35(11):e14267. doi: 10.1111/pai.14267 PMID: 38952781 Free PMC article. Updated. Preprint.
Desensitization and remission after peanut sublingual immunotherapy in 1- to 4-year-old peanut-allergic children: A randomized, placebo-controlled trial.
Kim EH, Bird JA, Keet CA, Virkud YV, Herlihy L, Ye P, Smeekens JM, Guo R, Yue X, Penumarti A, Qaqish B, Li Q, Kulis MD, Burks AW. Kim EH, et al. Among authors: virkud yv. J Allergy Clin Immunol. 2024 Jan;153(1):173-181.e10. doi: 10.1016/j.jaci.2023.08.032. Epub 2023 Oct 10. J Allergy Clin Immunol. 2024. PMID: 37815782 Free PMC article. Clinical Trial.
Open-label study of the efficacy, safety, and durability of peanut sublingual immunotherapy in peanut-allergic children.
Kim EH, Keet CA, Virkud YV, Chin S, Ye P, Penumarti A, Smeekens J, Guo R, Yue X, Li Q, Kosorok MR, Kulis MD, Burks AW. Kim EH, et al. Among authors: virkud yv. J Allergy Clin Immunol. 2023 Jun;151(6):1558-1565.e6. doi: 10.1016/j.jaci.2023.01.036. Epub 2023 Feb 23. J Allergy Clin Immunol. 2023. PMID: 36828080 Free PMC article. Clinical Trial.
45 results